Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06316843
Status:
RECRUITING
Last Update Posted:
2024-03-20
First Post:
2024-03-11
Brief Title:
Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2
Sponsor:
Bateman Horne Center
Organization:
Bateman Horne Center
Organization Data
Organization:
Bateman Horne Center
Class:
OTHER
Study ID:
BHC202 v21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bateman Horne Center
Lead Sponsor Class:
OTHER
Responsible Party:
LUCINDA BATEMAN MD
Responsible Party Title:
Medical Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Bateman Horne Center
Old Name:
None
Old Organization:
None